<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 697 study subjects, 38 (5.5%) had T2DM. Of those, 28 were treated with antiâ€“diabetic medications as follows: metformin: 
 <italic>n</italic> = 27, dipeptidyl peptidase-4 (DPP4) inhibitors: 
 <italic>n</italic> = 6, sulfonylurea: 
 <italic>n</italic> = 5, sodium-glucose transport 2 (SGLT-2) inhibitors: 
 <italic>n</italic> = 2, and glitazone: 
 <italic>n</italic> = 1. Three patients received a combination of oral anti-diabetics and insulin therapy. One subject received insulin treatment only. 
</p>
